In The News

RDCY Represents Rennova and Labs in Counterclaims Following Fee Dispute Suit

RDCY Represents Rennova and Labs in Counterclaims Following Fee Dispute Suit RDCY defends Rennova and Labs in counterclaims against fee dispute lawsuit, alleging breach of contract and unpaid fees.

Commentary: Why stroke misdiagnosis is a medical-malpractice crisis

Commentary: Why stroke misdiagnosis is a medical-malpractice crisis Explore why stroke misdiagnosis is a medical malpractice crisis—highlighting systemic failures, patient harm, and urgent reforms needed.

Troy A. Rafferty Appointed to Plaintiffs’ Leadership Council for Depo-Provera Litigation

Troy A. Rafferty named to Plaintiffs’ Executive Committee in national Depo‑Provera MDL, helping lead pretrial strategy for affected women.

Steward Health Care raided the coffers of its in-house malpractice insurer, leaving claimants, doctors in limbo

Parents sue hospital after premature baby’s neck fatally broken: Lawsuit

Lawsuit: Newborn’s neck broken by hospital staff

Hospital worker fatally broke newborn’s neck — and facility tried to hide it

Family Files Suit After Orlando Health Admits to Breaking Newborn’s Neck in NICU

Orlando Health Admits to Breaking Newborn’s Neck in NICU Family Files Suit After Orlando Health Admits to Breaking Newborn’s Neck in NICU Roughly two weeks later, her neck was broken by a healthcare provider, an injury that experts say could...

Troy Rafferty Plays Key Role in $425 Million Nexium and Prilosec Litigation

Nexium and Prilosec Litigation Troy Rafferty, a nationally recognized  attorney and shareholder at Rafferty Domnick Cunningham & Yaffa, has once again demonstrated his leadership in high-stakes pharmaceutical litigation. Rafferty played a central role in helping secure a $425 million global...

Troy Rafferty Wins Massive AndroGel Punitive Damages Case

Punitive Damages Case In a landmark legal victory, Troy Rafferty, a senior partner at Rafferty Domnick Cunningham & Yaffa, has successfully secured a significant punitive damages verdict against the makers of AndroGel, a testosterone replacement therapy product linked to serious...

Troy Rafferty Secures $19 Million Verdict for Accutane Plaintiffs

Roche Ordered to Pay $18 Million to Former Accutane Users Troy Rafferty Secures $19 Million Verdict for Accutane Plaintiffs Learn More: Troy Rafferty Secures $19 Million Verdict for Accutane Plaintiffs

Troy Rafferty played a critical role in Securing a $20 million Compensation Package for Survivors of Abuse at the Dozier School for Boys and the Okeechobee School for Boys

Compensation for Survivors of Abuse Learn More: Troy Rafferty played a critical role in Securing a $20 million Compensation Package for Survivors of Abuse at the Dozier School for Boys and the Okeechobee School for Boys